Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RAPPRAPP
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in RAPPORT THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 793,453 shares of RAPP (RAPPORT THERAPEUTICS INC), worth $33.1M as of 2026-Q2. The position was increased (+9.9% shares). RAPP represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$33.1M

Current Shares

793,453

Total Value Change

+$28.9M

Total Shares Change

+591,705

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
793,453
+9.9%
$33.1M0.0%$41.67
32
2026-Q1
Increased
721,622
+3.9%
$22.6M0.0%$27.85
30
2025-Q4
Increased
694,734
+30.3%
$21.1M0.0%$30.64
36
2025-Q3
Increased
533,403
+60.1%
$15.8M0.0%$27.97
40
2025-Q2
Increased
333,159
+5.5%
$3.8M0.0%$11.43
28
2025-Q1
Increased
315,663
+49.8%
$3.2M0.0%$10.05
37
2024-Q4
Increased
210,676
+4.4%
$3.7M0.0%$18.49
28
2024-Q3
New
201,748
-
$4.1M0.0%$21.33
37

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used